Walgreens, which reported a better-than-expected profit on flat sales for its second quarter Tuesday, has unveiled an expanded partnership with AmerisourceBergen that could give the
pharmacy operator an equity position and seat on the drug wholesaler’s board. Now Walgreens will expand its existing relationship with AmerisourceBergen into a 10-year comprehensive primary
distribution agreement for branded and generic pharmaceutical products.
Read the whole story at Chain Store Age »